Mecker G Möller

Prof. Dr. Mecker G Möller

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in The American Journal of Surgery
Verified
Journal Article
Closed access
EHEunice Y. Huang
Eunice Y. Huang
SKSamantha Knight
Samantha Knight
CGCamila Roginski Guetter
Camila Roginski Guetter
CDCatherine Hambleton Davis
Catherine Hambleton Davis
MMMecker G Möller
Mecker G Möller
MCMarie Crandall
Marie Crandall

14 June 2022 in Breast Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
OFOrli Friedman-Eldar
Orli Friedman-Eldar
JBJonathan Burke
Jonathan Burke
ISIago de Castro Silva
Iago de Castro Silva
CBCamille C. Baumrucker
Camille C. Baumrucker
FVFernando Valle
Fernando Valle
MMMecker G Möller
Mecker G Möller
Purpose Post-mastectomy breast reconstruction (PMBR) is an important component of breast cancer treatment, but disparities relative to insurance status persist despite legislation targeting the issue. We aimed to study this relationship in a large health system combining a safety-net hospital and a private academic center. Methods Data were collected on all patients who underwent mastectomy for breast cancer from 2011 to 2019 in a private academic center and an adjacent public safety-net hospital served by the same surgical teams. Multivariable logistic regression was used to assess the effect of insurance status on PMBR, controlling for covariates that included socioeconomic, demographic, and clinical factors. Results Of 1554 patients undergoing mastectomy for breast cancer, 753 (48.5%) underwent PMBR, of which 592 (79.9%) were privately insured, 50 (6.7%) Medicare, 68 (9.2%) Medicaid, and 31 (4.2%) uninsured. Multivariable logistic regression showed a significantly higher likelihood of not undergoing PMBR for uninsured (OR 6.0, 95% CI 3.7–9.8; p < 0.0001), Medicare (OR 1.9, (95% CI 1.2–3.0; p = 0.006), and Medicaid (OR 1.5, 95% CI 1.0–2.3; p = 0.04) patients compared with privately insured patients. Age, stage, race and ethnicity, and hospital type confounded this relationship. Conclusion Patients without health insurance have dramatically reduced access to PMBR compared to those with private insurance. Expanding access to this important procedure is essential to achieve greater health equity for breast cancer patients.

1 April 2014 in The American Journal of Surgery
Verified
Journal Article
Closed access
MMMecker G Möller
Mecker G Möller
JLJose Alejandro Lugo-Baruqui
Jose Alejandro Lugo-Baruqui
CMClara Milikowski
Clara Milikowski
CSChristopher J. Salgado
Christopher J. Salgado

16 March 2023 in Journal of Surgical Education
Verified
Journal Article
Closed access
LWLuccie Wo
Luccie Wo
SESarah A. Eidelson
Sarah A. Eidelson
CZCaiwei Zheng
Caiwei Zheng
JMJoelle Mouhanna
Joelle Mouhanna
PBParker Bussies
Parker Bussies
MMMecker G Möller
Mecker G Möller

28 March 2014 in Surgery Today
Verified
Journal Article
Closed access
PDF file
RVRoger M. Vega
Roger M. Vega
DPDavid Pechman
David Pechman
AEAyse Burcu Ergonul
Ayse Burcu Ergonul
CGCarmen Gomez-Fernandez
Carmen Gomez-Fernandez
MMMecker G Möller
Mecker G Möller

1 November 2018 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
LWLindsey Winer
Lindsey Winer
FMFrancisco I. Macedo
Francisco I. Macedo
AAAbdullah Alfawaz
Abdullah Alfawaz
ASAntonio Sommariva
Antonio Sommariva
GCGiovanni Cecchetto
Giovanni Cecchetto
MMMecker G Möller
Mecker G Möller
The management of pediatric abdominopelvic angiosarcoma remains unclear due to limited clinical experience. Herein, we presented the first 2 pediatric patients with abdominal angiosarcoma who were treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) after neoadjuvant therapy. The first patient is alive with recurrent disease at 1-year follow-up and the second patient remains disease free after 1 year. CRS and HIPEC should be considered as a therapeutic option in the management of pediatric abdominal angiosarcomas. A multi-institutional international shared registry is needed to further evaluate the role of CRS and HIPEC in inducing remission of abdominopelvic angiosarcomas in the pediatric population.